<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate whether there are any basic <z:hpo ids='HP_0001928'>abnormalities of coagulation</z:hpo> and fibrinolysis in <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo>, we measured serum levels of the MM isozyme of <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase (CK-MM), fibrin and fibrinogen degradation products (FDP), plasma levels of fibrinogen, antithrombin (AT), and D-dimer in 36 patients with Duchenne <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> (DMD), 11 with Becker <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> (BMD), 5 with Fukuyama <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> (FCMD), 5 with myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath> (MyD), and 5 with <z:hpo ids='HP_0007269'>spinal muscular atrophy</z:hpo> (SMA) type 2 </plain></SENT>
<SENT sid="1" pm="."><plain>FDP levels were elevated in the patients with DMD, BMD, and FCMD (1.0 to 84.9 microg/ml), but not in the patients with MyD and SMA type 2 </plain></SENT>
<SENT sid="2" pm="."><plain>In DMD, BMD, and FCMD, FDP levels significantly correlated with CK-MM, but not with age, fibrinogen, AT, D-dimer, and type of <z:mpath ids='MPATH_554'>dystrophy</z:mpath> (multiple regression analysis; r(2) = 0.814, P &lt; 0.0001) </plain></SENT>
<SENT sid="3" pm="."><plain>These findings suggested that enhanced coagulation and fibrinolysis are associated with <z:mp ids='MP_0000749'>muscle degeneration</z:mp> in patients with DMD, BMD, and FCMD </plain></SENT>
</text></document>